A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
Secondary Publication: COVID-19 Pandemic: Drug Development and Treatment
2021
Tokyo Women's Medical University Journal
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in late 2019. It has been rapidly spreading worldwide ever since. The majority of COVID-19 infections are asymptomatic or mildly symptomatic. However, old age or comorbidities can result in a cytokine storm, which eventually leads to death. To date, no drug has been clinically proven effective to treat COVID-19, and development of effective drugs against SARS-CoV-2 is urgently
doi:10.24488/twmuj.2021004
doaj:113b6040c3a246c09dac2af6a6c66e8f
fatcat:d3w7bgqhnrh2dkmvu7ehwp7r3q